Roche’s Oncology Pipeline Shows Promise in Treating Aggressive Brain Metastases
Roche’s trastuzumab, capecitabine, and tucatinib combo more than doubled median survival to 10 months in HER2+ breast cancer…
New ABB report shows energy efficiency investments rising in Malaysia – execution now defines industrial advantage
63 percent of industrial leaders in Malaysia have already invested in energy efficiency and a further 33 percent…
New ABB report shows energy efficiency investments rising in Malaysia – execution now defines industrial advantage
63 percent of industrial leaders in Malaysia have already invested in energy efficiency and a further 33 percent…